切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2019, Vol. 07 ›› Issue (03) : 137 -144. doi: 10.3877/cma.j.issn.2095-5820.2019.02.003

所属专题: 专题评论 文献

实验研究

外周血淋巴细胞绝对计数在结直肠癌和食管癌肿瘤进展与治疗前后免疫状态评估的临床应用研究
罗俐梅1, 罗娅1, 蔡宜含1, 冯伟华1, 蔡蓓1,()   
  1. 1. 610041 成都,四川大学华西医院实验医学科 临床检验医学研究中心
  • 收稿日期:2018-08-02 出版日期:2019-08-28
  • 通信作者: 蔡蓓

Clinical study of peripheral T-lymphocyte subsets and NK cells in evaluating the progress of colorectal cancer and esophageal cancer and immune status before and after surgery therapy

Limei Luo1, Ya Luo1, Yihan Cai1, Weihua Feng1, Bei Cai1,()   

  1. 1. Department of Laboratory Medicine, Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, Chengdu 610041, China
  • Received:2018-08-02 Published:2019-08-28
  • Corresponding author: Bei Cai
  • About author:
    Corresponding author: Cai Bei, Email:
引用本文:

罗俐梅, 罗娅, 蔡宜含, 冯伟华, 蔡蓓. 外周血淋巴细胞绝对计数在结直肠癌和食管癌肿瘤进展与治疗前后免疫状态评估的临床应用研究[J/OL]. 中华临床实验室管理电子杂志, 2019, 07(03): 137-144.

Limei Luo, Ya Luo, Yihan Cai, Weihua Feng, Bei Cai. Clinical study of peripheral T-lymphocyte subsets and NK cells in evaluating the progress of colorectal cancer and esophageal cancer and immune status before and after surgery therapy[J/OL]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2019, 07(03): 137-144.

目的

通过回顾性分析结直肠癌和食管癌患者手术前后外周血T淋巴细胞和NK细胞数据,探讨免疫细胞绝对计数对于肿瘤患者疾病监测的临床价值。

方法

回顾性分析我院64例结直肠癌和55例食管癌患者手术前后的外周血T淋巴细胞和NK细胞绝对计数与肿瘤病理结果、肿瘤分期的关系,以及动态变化表达结果。

结果

(1)结直肠癌Ⅰ期到Ⅳ期患者术前外周血CD3+、CD3+CD4+、CD3+CD8+T淋巴细胞计数均逐渐增加,其中仅CD3+CD4+、CD3+CD8+T淋巴细胞数目变化具有统计学意义(P<0.05)。术后结直肠癌患者各淋巴细胞亚群计数在TNM分期间无显著性差异。(2)食管癌患者术前各TNM分期间的T淋巴细胞亚群计数未见显著差异(P>0.05);术后食管癌患者CD3+、CD3+CD4+、CD3+CD8+T淋巴细胞计数在Ⅰ期和Ⅲ期均有显著性差异(P<0.05),总体表现为随TNM分期,淋巴细胞计数升高。(3)结直肠癌患者术前外周T淋巴细胞亚群计数具有肿瘤分化程度越高其数目越低的趋势,且伴有淋巴结或远处转移患者的术前T细胞数目增加,NK细胞数目降低,但仅CD3+CD8+T细胞增加有统计学意义(P<0.05);食管癌患者外周T淋巴细胞计数与肿瘤分化程度和肿瘤转移与否均无明显关系。(4)淋巴细胞计数的术前和术后动态分析显示,结直肠癌和食管癌患者外周T细胞亚群和NK细胞数目均表现为术后降低,随后逐渐增高趋势(P<0.05)。

结论

结直肠癌与食管癌外周各淋巴细胞亚群计数在TNM分期、肿瘤分化程度及肿瘤转移与否间的临床表现不同;结直肠癌患者可能因机体高肿瘤负荷及低分化肿瘤促进机体免疫反应性T细胞亚群增殖,而抑制NK细胞增生;手术创伤可导致肿瘤患者机体的T淋巴细胞和NK细胞一过性降低。

Objective

To explore the clinical value of absolute count of peripheral lymphocytes in monitoring immune status of cancer patients with surgery therapy, we retrospectively analyzed the absolute counts of peripheral T-lymphocytes subsets and NK cells before and after surgery in patients with colorectal cancer or esophageal cancer.

Methods

Retrospectively analyzed the absolute counts of T lymphocytes and NK cells and the correlation between lymphocytes counts and tumor progression or pathological staging as well as dynamic characteristics of lymphocyte counts during perioperation in 64 cases of colorectal cancer and 55 cases of esophageal cancer with surgery therapy.

Results

(1) In patients with colorectal cancer, CD3+T lymphocytes, CD3+ CD4+ T lymphocytes and CD3+CD8+ T lymphocytes counts gradually increased from stageⅠto stageⅣ, but only CD3+CD4+ T lymphocytes and CD3+CD8+T lymphocytes increased significantly (P<0.05). No striking difference were found on the absolute counts of lymphocytes from stage Ⅰ to stageⅣafter surgery therapy. (2) In patients with esophageal cancer, the counts of preoperative T lymphocytes subsets in Ⅰ-Ⅳ stage has no significant difference (P>0.05); and the count of postoperative CD3+, CD3+CD4+, CD3+CD8+T lymphocytes gradually increased from stageⅠto stageⅢ (P<0.05). (3) In higher differentiated tumor lower preoperative counts of peripheral T lymphocytes existed in the patients with colorectal cancer (P>0.05). Patients with metastasis have more counts of T lymphocytes subsets and lower count of NK cells than that of patients without metastasis, and only CD3+CD8+T lymphocytes significantly increased (P<0.05). There was no association between peripheral T lymphocytes count and degree of tumor differentiation or tumor metastasis in patients with esophageal cancer. (4) Dynamic analysis of absolute counts of perioperative T lymphocyte subsets and NK cells showed that postoperative T lymphocytes and NK cells firstly strikingly decreased (P<0.05), then increased (P<0.05).

Conclusions

The correlation of peripheral T lymphocytes or NK cells count with TNM staging, degree of tumor differentiation as well as tumor metastasis was not the same between colorectal cancer and esophageal cancer. In patients with colorectal cancer the responsively increasing preoperative T lymphocytes counts and suppression of preoperative NK cells may be caused by high tumor burden and poorly differentiated tumor; surgery trauma could cause transiently decrease of postoperative T lymphocytes and NK cells.

表1 患者基本信息
图1 结直肠癌和食管癌患者手术治疗前后外周血T淋巴细胞亚群或NK细胞绝对计数在肿瘤TNM分期的表达分析
图2 结直肠癌和食管癌患者手术治疗前T淋巴细胞亚群或NK细胞绝对计数表达与肿瘤转移和病理类型的关系分析
表2 结直肠癌和食管癌患者手术前后外周血各淋巴细胞亚群计数比较(±SD)
图3 结直肠癌和食管癌患者手术治疗前后T淋巴细胞亚群或NK细胞计数动态表达分析
1
董颖,杨文君. 消化道恶性肿瘤流行病学特征与发病现状分析[J]. 医学综述, 2014,20(3):429-431.
2
Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle[J]. Immunity, 2013,39(1):1-10.
3
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual[M]. 7th ed. New York: Springer, 2012.
4
Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration[J]. Dis Esophagus, 2009,22(1):1-8.
5
梁新强,刘海洲,利基林,等. 乳腺癌患者外周血T淋巴细胞和NK细胞水平分析[J]. 广西医学, 2013,35(2):132-134.
6
张琛琛. 肺腺癌与肺鳞癌肿瘤浸润淋巴细胞的特点分析[D]. 杭州:浙江大学, 2016.
7
Karagöz B, Bilgi O, Gümüs M, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients[J]. Med Oncol, 2010,27(1):29-33.
8
严明基,陈炳光,赵鹏. 外周血T淋巴细胞亚群表达水平对恶性肿瘤病理分期的评估价值[J]. 中国卫生工程学, 2018,17(3):428-429.
9
吴映娥. 恶性肿瘤患者外周血T淋巴细胞亚群的改变及其临床意义[D]. 汕头: 汕头大学, 2007.
10
萧剑军,彭杰文,何洁冰,等. 晚期恶性肿瘤患者CD8及CD28 T淋巴细胞亚群结果分析[J]. 广东医学, 2002,23(S1):12-13.
11
裘宇容,杨春莉,陈炼波等. 原发性肝癌患者CD8+CD28-和CD8+CD28+细胞亚群的分析[J]. 第一军医大学学报, 2002,22(1):72-73.
12
黄庆梅,覃锦耀. CD4+CD25+细胞和CD8+CD28-调节性T细胞在原发性肝癌患者外周血中的水平变化[J]. 检验医学, 2010,25(9):705-707.
13
贾丽,谢晓宝,邱国强,等. 多发性骨髓瘤患者外周血CD4+CD25+和CD8+CD28-调节性T细胞研究[J]. 中国免疫学杂志, 2009,25(11):1033-1037.
14
Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function[J]. Annu Rev Immunol, 2012,30(3):531-564.
15
Shen LS, Wang J, Shen DF, et al. CD4+ CD25+ CD127 low/−, regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression[J]. Clin Immunol, 2009,131(1):109-118.
16
Gomatos IP, Alevizos L, Kalathaki O, et al. Changes in T-lymphocytes′ viability after laparoscopic versus open cholecystectomy[J]. Int Surg, 2015,100(4):696-701.
17
彭聿平,邱一华. 手术应激与免疫抑制[J]. 生理科学进展, 2006,37(1):31-36.
[1] 袁庆港, 刘理想, 张亮, 周世振, 高波, 丁超, 管文贤. 尿素-肌酐比值(UCR)可预测结直肠癌患者术后的长期预后[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 506-509.
[2] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[3] 宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[4] 薛春娥, 赵娟娟, 刘韦成, 张义亮, 马毓晗, 李迎巧. CD4+CD25+foxp3+调节性T细胞通过NKG2D增强急性髓性白血病中NK细胞毒性[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 212-219.
[5] 赵泽云, 李建男, 王旻. 中性粒细胞胞外诱捕网在结直肠癌中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 524-528.
[6] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[7] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[8] 孙晗, 于冰, 武侠, 周熙朗. 基于循环肿瘤DNA 甲基化的结直肠癌筛查预测模型的构建与验证[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 500-506.
[9] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[10] 段伟, 刘飞, 许光源, 程宇豪, 陈星. 食管癌调强放疗计划剂量学参数差异对放射性肺炎发生及严重程度的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 320-324.
[11] 陶金华, 陈珊珊, 陈晓四. 阿帕替尼联合替吉奥治疗晚期食管癌的疗效与安全性影响因素评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 325-329.
[12] 高静, 夏婷婷. 血清乳酸脱氢酶、中性粒细胞/淋巴细胞比值、血浆纤维蛋白原/前白蛋白比值对晚期结直肠癌患者姑息化疗效果与不良反应的评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 203-207.
[13] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
[14] 高鹏强, 林军鹏, 王佩元, 林辉, 周航, 魏文巍, 柳硕岩, 王枫. 胸段食管鳞状细胞癌中锁骨上淋巴结转移对预后的影响:一项大型回顾性研究[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 211-218.
[15] 李春光, 杨洋, 李斌, 华荣, 李志刚. 完全腹腔镜下管状胃制作技术在食管癌McKeown手术中的应用[J/OL]. 中华胸部外科电子杂志, 2024, 11(04): 219-224.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?